Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide antibiotics

R E Hancock1

  • 1Department of Microbiology and immunology, University of British Columbia, Vancouver, Canada.

Lancet (London, England)
|February 8, 1997
PubMed
Summary
This summary is machine-generated.

Classical antibiotics are failing due to resistance. Peptide antibiotics, particularly cationic peptides, offer a promising alternative. Their novel mechanism of membrane disruption may overcome rapid resistance development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and Characterization of Porins from H. pylori.

Methods in molecular medicine·2011
Same author

The therapeutic potential of cationic peptides.

Expert opinion on investigational drugs·2005
Same author

Characterization of, and immune responses of mice to, the purified OmpA-equivalent outer membrane protein of Pasteurella multocida serotype A:3 (Omp28).

Veterinary microbiology·2002
Same author

Cationic peptides: effectors in innate immunity and novel antimicrobials.

The Lancet. Infectious diseases·2002
Same author

In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide.

Journal of pharmaceutical sciences·2001
Same author

Interaction of cationic antimicrobial peptides with model membranes.

The Journal of biological chemistry·2001
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Microbiology
  • Pharmacology
  • Biochemistry

Background:

  • The rise of antibiotic resistance threatens modern medicine.
  • No new classes of antibacterial agents have been approved in three decades.
  • Classical antibiotics are becoming increasingly ineffective against bacterial infections.

Purpose of the Study:

  • To explore the potential of peptide antibiotics as a novel therapeutic strategy.
  • To investigate the advantages of cationic peptides in combating bacterial infections.
  • To assess the likelihood of resistance development against peptide antibiotics.

Main Methods:

  • Review of current research on peptide antibiotics.
  • Analysis of the mechanism of action of cationic peptides.

Related Experiment Videos

  • Examination of clinical trial data for peptide-based drugs.

    • Main Results:

    • Thousands of peptide antibiotic molecules have been synthesized.
    • A few peptide antibiotics are progressing into clinical trials.
    • Peptide antibiotics demonstrate rapid bacterial killing via cell membrane disruption.

    Conclusions:

    • Peptide antibiotics, especially cationic types, represent a significant advancement in antibacterial therapy.
    • The physical disruption mechanism of peptide antibiotics may circumvent common resistance pathways.
    • Further development of peptide antibiotics is crucial to address the growing threat of antimicrobial resistance.